(Q53658442)

English

Effect of PNPLA3 rs738409 variant (I148 M) on hepatic steatosis, necroinflammation, and fibrosis in Japanese patients with chronic hepatitis C.

scientific article published on 26 November 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/25543233

Effect of PNPLA3 rs738409 variant (I148 M) on hepatic steatosis, necroinflammation, and fibrosis in Japanese patients with chronic hepatitis C. (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/25543233

1 reference

based on heuristic

inferred from title

author name string

Kohichiroh Yasui

1

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/25543233

Takahisa Kawaguchi

2

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/25543233

Toshihide Shima

3

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/25543233

Hironori Mitsuyoshi

4

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/25543233

Kojiro Seki

5

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/25543233

Rei Sendo

6

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/25543233

Masayuki Mizuno

7

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/25543233

Yoshito Itoh

8

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/25543233

Fumihiko Matsuda

9

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/25543233

Takeshi Okanoue

10

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/25543233

publication date

26 November 2014

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/25543233

Journal of Gastroenterology

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/25543233

50

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/25543233

8

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/25543233

887-893

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/25543233

Biochemical surrogate markers of liver fibrosis and activity in a randomized trial of peginterferon alfa-2b and ribavirin

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-1018-Z

21 January 2018

Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data.

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-1018-Z

21 January 2018

Mechanisms and significance of liver steatosis in hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-1018-Z

21 January 2018

Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3.

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-1018-Z

21 January 2018

Steatosis and hepatic expression of genes regulating lipid metabolism in Japanese patients infected with hepatitis C virus.

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-1018-Z

21 January 2018

Measurement and determinants of the natural history of liver fibrosis in hepatitis C virus infection: a cross sectional and longitudinal study

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-1018-Z

21 January 2018

Disease progression in chronic hepatitis C: modifiable and nonmodifiable factors

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-1018-Z

21 January 2018

Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-1018-Z

21 January 2018

Homozygosity for the patatin-like phospholipase-3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease.

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-1018-Z

21 January 2018

The association of genetic variability in patatin-like phospholipase domain-containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-1018-Z

21 January 2018

Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-1018-Z

21 January 2018

Variant in PNPLA3 is associated with alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-1018-Z

21 January 2018

Common polymorphism in the PNPLA3/adiponutrin gene confers higher risk of cirrhosis and liver damage in alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-1018-Z

21 January 2018

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-1018-Z

21 January 2018

Genetic polymorphisms of the human PNPLA3 gene are strongly associated with severity of non-alcoholic fatty liver disease in Japanese

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-1018-Z

21 January 2018

A proposed system for the nomenclature of hepatitis C viral genotypes

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-1018-Z

21 January 2018

Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-1018-Z

21 January 2018

Viral genotype-specific role of PNPLA3, PPARG, MTTP, and IL28B in hepatitis C virus-associated steatosis

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-1018-Z

21 January 2018

Impact of PNPLA3 polymorphisms on the development of hepatocellular carcinoma in patients with chronic hepatitis C virus infection.

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-1018-Z

21 January 2018

No correlation between PNPLA3 rs738409 genotype and fatty liver and hepatic cirrhosis in Japanese patients with HCV

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-1018-Z

21 January 2018

The PNPLA3 rs738409 148M/M genotype is a risk factor for liver cancer in alcoholic cirrhosis but shows no or weak association in hepatitis C cirrhosis

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-1018-Z

21 January 2018

PNPLA3 rs738409C/G polymorphism in cirrhosis: relationship with the aetiology of liver disease and hepatocellular carcinoma occurrence.

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-1018-Z

21 January 2018

Association between the PNPLA3 (rs738409 C>G) variant and hepatocellular carcinoma: Evidence from a meta-analysis of individual participant data

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-1018-Z

21 January 2018

A follow-up study to determine the value of liver biopsy and need for antiviral therapy for hepatitis C virus carriers with persistently normal serum aminotransferase

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-1018-Z

21 January 2018

Donor PNPLA3 rs738409 genotype affects fibrosis progression in liver transplantation for hepatitis C.

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-1018-Z

21 January 2018

A sequence variation (I148M) in PNPLA3 associated with nonalcoholic fatty liver disease disrupts triglyceride hydrolysis

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-1018-Z

21 January 2018

A feed-forward loop amplifies nutritional regulation of PNPLA3

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-1018-Z

21 January 2018

Expression, regulation, and triglyceride hydrolase activity of Adiponutrin family members.

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-1018-Z

21 January 2018

Chronic overexpression of PNPLA3I148M in mouse liver causes hepatic steatosis

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-1018-Z

21 January 2018

Recombinant PNPLA3 protein shows triglyceride hydrolase activity and its I148M mutation results in loss of function

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-1018-Z

21 January 2018

PNPLA3 has retinyl-palmitate lipase activity in human hepatic stellate cells

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-1018-Z

21 January 2018

Adiponutrin functions as a nutritionally regulated lysophosphatidic acid acyltransferase

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-1018-Z

21 January 2018

Role of patatin-like phospholipase domain-containing 3 on lipid-induced hepatic steatosis and insulin resistance in rats

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-1018-Z

21 January 2018

Patatin-like phospholipase domain-containing 3/adiponutrin deficiency in mice is not associated with fatty liver disease

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-1018-Z

21 January 2018

Pnpla3/Adiponutrin deficiency in mice does not contribute to fatty liver disease or metabolic syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-1018-Z

21 January 2018

Distinct, alcohol-modulated effects of PNPLA3 genotype on progression of chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-1018-Z

21 January 2018

Genetic variation in the PNPLA3 gene is associated with alcoholic liver injury in caucasians

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-1018-Z

21 January 2018

Impact of comorbid hepatic steatosis on treatment of chronic hepatitis C in Japanese patients and the relationship with genetic polymorphism of IL28B, PNPLA3 and LDL receptor.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25543233

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modulation of the effect of PNPLA3 I148M mutation on steatosis and liver damage by alcohol intake in patients with chronic hepatitis C

1 reference

https://pubmed.ncbi.nlm.nih.gov/25543233

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relationship of aminotransferases to liver histological status in chronic hepatitis C

1 reference

https://pubmed.ncbi.nlm.nih.gov/25543233

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Report of the committee on the classification and diagnostic criteria of diabetes mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/25543233

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of patatin-like phospholipase-3 (rs738409 C>G) polymorphism on fibrosis progression and steatosis in chronic hepatitis C

1 reference

https://pubmed.ncbi.nlm.nih.gov/25543233

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A proposed system for the nomenclature of hepatitis C viral genotypes

1 reference

https://pubmed.ncbi.nlm.nih.gov/25543233

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Patatin-Like phospholipase domain-containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C

1 reference

https://pubmed.ncbi.nlm.nih.gov/25543233

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Patatin-like phospholipase domain-containing 3 (PNPLA3) I148M (rs738409) affects hepatic VLDL secretion in humans and in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/25543233

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00535-014-1018-Z

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/25543233

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/25543233

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53658442&oldid=1586544859"